Comparison Qualigen Therapeutics, Inc. Common Stock (QLGN) with Competitors
Qualigen Therapeutics, Inc. Common Stock (QLGN) industry is Biotechnology.
Profit Margin
QLGN-38.25%
Industry-0.77%
Upside-37.48%
Operating Margin
QLGN-59.58%
Industry-2055.25%
Upside+1995.67%
Debt-to-Equity
QLGN8.40%
Industry28.27%
Upside-70.28%
P/E
QLGN-0.44
Industry-20.52
Upside+2007.72%
P/S
QLGN1.12
Industry10.01
Upside-88.83%
P/B
QLGN0.05
Industry5.15
Upside-98.95%